Important Notice for Replimune Group Shareholders on Class Action Eligibility

Attention Replimune Group, Inc. Shareholders

Shareholders who incurred losses while investing in Replimune Group, Inc. (NASDAQ: REPL) are advised to reach out to The Gross Law Firm regarding an ongoing class action lawsuit. This notice emerges as the firm suggests that individuals who bought shares of Replimune during the class period from November 22, 2024, to July 21, 2025, may have a claim due to the alleged dissemination of materially false and misleading information by the company’s representatives.

Allegations Against Replimune Group

The claims state that during the specified period, officials from Replimune purportedly overstated the prospects of their IGNYTE clinical trial. It is alleged that they were either aware or should have been aware of material issues regarding the trial's adequacy and constraints prior to the statements made, which led the FDA to reject the trial as insufficiently controlled. Consequently, this lack of transparency led to a significant disconnect between the company’s public statements and its actual operational effectiveness, ultimately impacting stock prices adversely for the investors involved.

Class Period and Appointments

Shareholders must act swiftly as the deadline to seek lead plaintiff status in this case is September 22, 2025. Registration for participation in the lawsuit can be done without any cost. Moreover, once registered, shareholders will gain access to monitoring tools to keep updated on the case’s progress. However, being appointed as a lead plaintiff is not a prerequisite for participating in the class action recovery process.

It’s crucial for affected shareholders to now reflect on their investment decisions and take steps toward protecting their rights. The Gross Law Firm offers its services as a nationally recognized entity that advocates for investors ravaged by corporate malpractice, misrepresentation, and legal improprieties in business practices.

Why Choose The Gross Law Firm?

The Gross Law Firm is committed to upholding investor rights and pursuing justice for those affected by faulty business actions. They stand firm against dishonest practices that harm stakeholder interests and are active in litigating cases where investor losses stem from companies disseminating misleading or false information. The firm aims to hold these companies accountable to enforce proper corporate citizenship and ensure that investors receive due compensation.

If you believe you have suffered losses due to Replimune's actions, it is recommended to review your eligibility and reach out promptly.

For more information on how to join the class action or to contact The Gross Law Firm, visit this link. Their offices are located at 15 West 38th Street, 12th floor, New York, NY, 10018, and for any inquiries, they can be reached at (646) 453-8903.